These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10211537

  • 21. [Multicenter evaluation on the efficacy and safety of sparfloxacin in the treatment of acute bacterial infections].
    Cai Y, Liang D, Xu N, Miao J, Qiu D, Wen C.
    Hua Xi Yi Ke Da Xue Xue Bao; 2002 Apr; 33(2):291-3, 325. PubMed ID: 12575213
    [Abstract] [Full Text] [Related]

  • 22. Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
    Adam D, Glaser-Caldow E, Wachter J, Brueckner OJ, Hein J, Kroemer B, Hirsch J.
    Clin Ther; 2001 Apr; 23(4):585-95. PubMed ID: 11354392
    [Abstract] [Full Text] [Related]

  • 23. Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
    Darkes MJ, Perry CM.
    Am J Respir Med; 2003 Apr; 2(2):175-201. PubMed ID: 14720016
    [Abstract] [Full Text] [Related]

  • 24. Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study.
    Donowitz GR, Brandon ML, Salisbury JP, Harman CP, Tipping DM, Urick AE, Talbot GH.
    Clin Ther; 1997 Apr; 19(5):936-53. PubMed ID: 9385482
    [Abstract] [Full Text] [Related]

  • 25. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
    Sokol WN, Sullivan JG, Acampora MD, Busman TA, Notario GF.
    Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
    [Abstract] [Full Text] [Related]

  • 26. Once daily clarithromycin extended-release vs twice-daily amoxicillin/clavulanate in patients with acute bacterial sinusitis: a randomized, investigator-blinded study.
    Riffer E, Spiller J, Palmer R, Shortridge V, Busman TA, Valdes J.
    Curr Med Res Opin; 2005 Jan; 21(1):61-70. PubMed ID: 15881476
    [Abstract] [Full Text] [Related]

  • 27. The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia.
    Hoeffken G, Meyer HP, Winter J, Verhoef L, CAP1 Study Group.
    Respir Med; 2001 Jul; 95(7):553-64. PubMed ID: 11453311
    [Abstract] [Full Text] [Related]

  • 28. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
    Gehanno P, Berche P.
    J Antimicrob Chemother; 1996 May; 37 Suppl A():105-14. PubMed ID: 8737130
    [Abstract] [Full Text] [Related]

  • 29. Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis.
    Stefansson P, Jacovides A, Jablonicky P, Sedani S, Staley H.
    Rhinology; 1998 Dec; 36(4):173-8. PubMed ID: 9923060
    [Abstract] [Full Text] [Related]

  • 30. Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis.
    Marchi E.
    Curr Med Res Opin; 1990 Dec; 12(1):19-24. PubMed ID: 2140546
    [Abstract] [Full Text] [Related]

  • 31. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Zuck P, Vogel F, McIvor A, Peirzchala W, Smakal M, Staley H, Marr C.
    J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
    [Abstract] [Full Text] [Related]

  • 32. Oral empiric treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing sparfloxacin with roxithromycin. The Scandinavian Sparfloxacin Study Group.
    Ortqvist A, Valtonen M, Cars O, Wahl M, Saikku P, Jean C.
    Chest; 1996 Dec; 110(6):1499-506. PubMed ID: 8989068
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of a complex homeopathic medication (Sinfrontal) in patients with acute maxillary sinusitis: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Zabolotnyi DI, Kneis KC, Richardson A, Rettenberger R, Heger M, Kaszkin-Bettag M, Heger PW.
    Explore (NY); 2007 Dec; 3(2):98-109. PubMed ID: 17362845
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections.
    Dowzicky M, Nadler H, Dorr MB, Acusta A, Talbot GH.
    Clin Ther; 1999 May; 21(5):790-805; discussion 789. PubMed ID: 10397375
    [Abstract] [Full Text] [Related]

  • 35. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
    Nalepa P, Dobryniewska M, Busman T, Notario G.
    Curr Med Res Opin; 2003 May; 19(5):411-20. PubMed ID: 13678478
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of ciprofloxacin and clarithromycin in acute bacterial exacerbations of complicated chronic bronchitis: interim analysis. Bronchitis Study Group.
    Anzueto A, Niederman MS, Haverstock DC, Tillotson GS.
    Clin Ther; 1997 May; 19(5):989-1001. PubMed ID: 9385486
    [Abstract] [Full Text] [Related]

  • 37. Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, DeAbate CA, Haverstock D, Aneiro L, Church D.
    Respir Med; 2000 Jan; 94(1):18-27. PubMed ID: 10714475
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R, Berg O, Gehanno P, Leiberman A, Martinkenas JL, Nikolaidis P, Arvis P, Alefelder M, Reimnitz P.
    Eur Arch Otorhinolaryngol; 2003 Apr; 260(4):186-94. PubMed ID: 12709801
    [Abstract] [Full Text] [Related]

  • 39. Role for 5-day, once-daily extended-release clarithromycin in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Busman TA, Norris S, Notario GF.
    Curr Med Res Opin; 2007 Feb; 23(2):459-66. PubMed ID: 17288699
    [Abstract] [Full Text] [Related]

  • 40. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
    Gotfried M, Notario G, Spiller J, Palmer R, Busman T.
    Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.